ETOLOCK-P Tablet is formulated for effective therapeutic relief, disease management, and supporting patient recovery under clinical guidance.
ETOLOCK-P Tablets by MK Healthcare are a specialized analgesic and anti-inflammatory formulation, engineered to provide rapid, effective relief from moderate to severe pain. Specifically categorized under our Orthocare range, this powerful combination of Etodolac and Paracetamol is trusted by healthcare professionals to manage musculoskeletal conditions, including arthritis, osteoarthritis, rheumatoid pain, and post-traumatic inflammation. By acting directly on the source of pain, ETOLOCK-P helps restore mobility and improve the daily quality of life for patients suffering from chronic pain.
The efficacy of ETOLOCK-P lies in its dual-action therapeutic profile. Etodolac, a selective non-steroidal anti-inflammatory drug (NSAID), works by inhibiting the enzymes responsible for prostaglandins synthesis-the key chemicals that trigger pain, swelling, and inflammation in the body. This is complemented by the fast-acting analgesic and antipyretic properties of Paracetamol, which provides rapid pain suppression. Together, this synergy offers a potent solution that not only reduces inflammation but also manages fever and acute pain with high precision and clinical reliability.
Quality and consumer safety remain the hallmarks of MK Healthcare?s production standards. ETOLOCK-P is manufactured in our state-of-the-art, WHO-GMP and ISO-certified facilities, ensuring that every batch meets stringent international pharmaceutical benchmarks. To ensure optimal product stability and protect the tablets from moisture or atmospheric contamination, they are presented in premium blister packaging of 10x10 tablets. This robust, hygienic packaging ensures that each dose retains its full therapeutic potency until the moment of administration, providing pharmacists and patients with peace of mind.
For pharmaceutical distributors and medical professionals seeking to expand their reach in the pain management segment, MK Healthcare offers high-growth PCD Pharma Franchise opportunities for ETOLOCK-P. We provide our partners with comprehensive support, including exclusive monopoly rights, high-impact marketing materials, and a consistent, reliable supply chain. By integrating ETOLOCK-P into your portfolio, you are offering a high-demand, evidence-based treatment to healthcare providers, solidifying your position as a trusted provider of quality orthocare solutions in your territory.